ExpreS2ion Biotech Holding AB (publ)

kr 0.93As of Sun 8 Nov 2026, 12:00 UTC
STO:EXPRS2Healthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (44.35%)
Div yield —
ROE (85.17%)
Biotechnology
Beta (5Y) 2.38
PE TTM —
TSR TTM (94.52%)
Mkt cap kr 22.04M
ROIC (62.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.09
17.32%
(43.93%)
Hold 11|9|4|5|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.02
2.80%
12.68%
12.99%
27.95%
Revenuekr M
1.559
1.606
1.696
1.674
10.10%
8.14%
10.53%
10.96%
Peers (US$2.228M)
Cap (US$)
PE
3.597M
—
Capital
TTM
5Y
10Y
Leveragex
1.253
0.088
0.095
EBIT/Intx
0.486
0.236
0.265
Own earn%
(37.05)
123.01
127.48
Sh yield%
40.35
65.70
61.55
Owners
Insiders/Inst%
5.96
68.63
Short interest%
1.72
SBC / revenue%
5.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
16–28
$1 testx
—
Incr. ROIC%
13